Company / PP&E (Net)
PROCEPT BioRobotics Corp PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$30.4M
FY2025
5-year range
$5.0M / $30.4M
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#119 of 150
Health Care
What the data says
PROCEPT BioRobotics Corp's pp&e (net) of $30M is lower than 79% of companies in the Health Care sector (FY2025). PP&E (Net) has fluctuated over the past 6 years, ranging from $5M in FY2021 to $30M in FY2025.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +29.7%.
Improved from $29M to $30M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +52.0%
- 5-Year CAGR
- +29.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 150This company $30.4M Sector average $1.4B
▼
-97.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +29.7%, indicating consistent growth.
- In FY2025, pp&e (net) increased 13.8% year-over-year.
- Ranks #119 out of 150 companies in the Health Care sector.
- Lowest pp&e (net) in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.4M | +13.8% |
| FY2024 | $26.7M | -7.1% |
| FY2023 | $28.7M | +232.1% |
| FY2022 | $8.7M | +71.6% |
| FY2021 | $5.0M | -39.0% |
| FY2020 | $8.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026